NewsRoom Articles - Page 479 of 491

FridayMay 05, 2017 2:37 pm

India Globalization Capital, Inc. (NYSE: IGC) Engages a Critical Point in Cannabis History

Cannabis is now legal medically or recreationally in 28 states in the U.S., and companies such as India Globalization Capital, Inc. (NYSE MKT: IGC) are developing revolutionary cannabinoid-based combination pharmaceutical therapies. Cannabis’ history doesn’t begin in the 1960s. Scientists have dated burned cannabis seeds found in Siberia to 3,000 B.C., and mummified psychoactive marijuana has been found in tombs of individuals buried around 2,500 B.C. Fast forward a few thousand years and add laws, regulations, and cultural stigma, and behold one of the most disputed substances. In the 1850s, recreational cannabis was considered fashionable in the U.S., and it was…

ThursdayMay 04, 2017 12:27 pm

India Globalization Capital (NYSE: IGC) Strategically Staking Claims in the Medical Marijuana Markets

In a testament to its medical efficacy, 29 states and the District of Columbia have now legalized medical marijuana. This groundswell with state sanction and now widespread public acceptance has started a stampede of companies jockeying to profit from legalization. From the sale of oils and extracts to specialized cultivation, multiple companies are rushing into this new market hoping to cash in on surging demand. However, rushing in just might not be the right approach to making real money in this sector. There’s an old adage that says the way to create real wealth is to find out where everyone…

WednesdayMay 03, 2017 1:04 pm

ABcann Medicinals Could Join the Ranks of Canadian Licensed Marijuana Producers with Rising Valuations after IPO

All eyes are on ABcann Medicinals, Inc. as it prepares to go public. The company, which is already growing rapidly, wants to expand its footprint in Canada and take advantage of potential international opportunities. Additional production facilities are planned to meet the expected supply short fall in the Canadian market when marijuana for recreational use is legalized next year. With its state-of-the-art cultivation facilities and established patient-client care systems, ABcann has the infrastructure in place to profit from that billion-dollar Canadian marijuana market. With adult use of marijuana set for legalization by July 1, 2018, the Canadian marijuana market is…

WednesdayMay 03, 2017 9:00 am

Paws Firmly Planted for Growth in Multibillion-Dollar Pet Health Market

CannabisNewsWire Editorial Coverage: Pets are the loyal, much-loved companions we humans can’t seem to live without, and when a beloved pet becomes ill, owners will generally do whatever it takes to restore these beloved companion animals to health. Various public companies are accomplishing the two-fold mission of improving the health of our four-footed friends while giving investors the opportunity to capitalize on a multibillion-dollar industry. India Globalization Capital, Inc. (NYSE: IGC) (IGC Profile), VCA, Inc. (NASDAQ: WOOF), PetMed Express, Inc. (NASDAQ: PETS), Blue Buffalo Pet Products, Inc. (NASDAQ: BUFF) and IDEXX Laboratories, Inc. (NASDAQ: IDXX) are just some of the…

TuesdayMay 02, 2017 2:20 pm

ABcann Medicinals Set to Launch IPO This Week on TSXV

According to efficient markets theory, the chances of finding hundred-dollar bills lying on the ground are slim, at best. When one is dropped, some well-informed investor is quick to pick it up. However, with Abcann Medicinals set to launch its initial public offering (IPO) on the TSX Venture Exchange on May 4, the chances of finding those elusive hundreds have increased significantly. Investors will have an opportunity to take up shares in one of Canada’s major legal cannabis producers. With the marijuana recreational market in Canada set for legalization, the Abcann Medicinals IPO will level the playing field and offer…

MondayMay 01, 2017 1:18 pm

ChineseInvestors.com, Inc. (CIIX) Set to Capitalize on Meteoric Growth of CBD Market

The chemical in marijuana that causes euphoria is delta-9 tetrahydrocannabinol, or THC. There are also over 100 other cannabinoid chemicals in the plant, including cannabidiol (CBD), one of the main active chemical compounds found in marijuana. CBD doesn’t make people high, isn’t intoxicating or addictive, and is gaining widespread acceptance as a natural and effective medicinal treatment for multiple disorders. Both anecdotal evidence and pre-clinical research have pointed to CBD as having a broad range of beneficial therapeutic uses, including anti-seizure, antioxidant, neuro-protective, anti-inflammatory, analgesic, anti-tumor, anti-anxiety, and anti-psychotic properties. CBD oil has already been legalized in all 50 U.S.…

FridayApr 28, 2017 9:21 am

SinglePoint, Inc. (SING) is Poised for the Marijuana Tipping Point, Explains CEO in Recent Podcast

After ballots on November 8, 2016, seven more states, including California and Florida, will now permit the use of marijuana for either medical or recreational use. Currently, 29 states and the District of Columbia have passed initiatives or laws legalizing medical marijuana or regulating its adult use like alcohol or tobacco. Yet cannabis remains illegal under federal law, and banks are reluctant to open accounts for marijuana shops and dispensaries, leading to a variety of unfortunate results. It seems obvious that the current disharmony between state and federal law is not maintainable, and a tipping point when financial institutions open…

ThursdayApr 27, 2017 3:15 pm

SinglePoint, Inc. (SING) Finds Growth Potential Outside of Mobile Payments Market

Being a publicly traded holding company gives SinglePoint, Inc. (OTC: SING) a chance to target candidate companies and help them grow. Such has been the case on the mobile technology and mobile marketing fronts. By connecting client companies to their best target markets, mobile technology can be made available at reasonable rates, but an interest in these organizations means profit potential for SinglePoint. However, the company hasn’t limited its investment opportunities. The cannabis industry is thriving as legalization (medical and/or recreational) has occurred in 29 states and counting. Expansion beyond mobile payments has enabled the company to find more opportunities…

WednesdayApr 26, 2017 3:48 pm

ChineseInvestors.com, Inc. (CIIX) Raises Funds through a Private Placement, Sales of Equities, and Preferred Stock Offerings

ChineseInvestors.com, Inc. (OTCQB: CIIX) is raising funds in a series of offerings, equity sales and a private placement to meet its liquidity needs, even as it reported a 95% gain in its year-over-year operating revenues for the three months ended February 28, 2017. It has begun a private placement of a new series of its preferred stock to its Canadian investors. In 2016, it realized $2.3 million in proceeds from its stock sales of Medicine Man Technologies, Inc. ChineseInvestors.com is a company which, in real-time in the Chinese language, provides analysis and educational services. It also offers consulting and advertising…

MondayApr 24, 2017 2:04 pm

India Globalization Capital, Inc. (NYSE: IGC) is a First Mover in Cannabinoid Combination Therapies

The success of the Walkman back in the 1980s is testament to the power of getting to market first. By some accounts, Sony sold over 200 million units of its innovative portable cassette player (http://nnw.fm/H6spU). Now, India Globalization Capital, Inc. (NYSE MKT: IGC) is taking a leaf from the Sony playbook. This pioneering company is a ‘first mover’ in the cannabinoid combination therapy space. IGC is developing a portfolio of products that use cannabinoids in conjunction with existing drugs to tackle chronic pain and a variety of other debilitating medical conditions. Chronic pain from a range of ailments plagues millions…

News and publishing service for cannabis related companies

Contact us: 303.498.7722